Mike_1977
Well-known member
The World Health Organization just released guidelines about using glucagon-like peptide-1 medications for weight management. They're suggesting these drugs can be used long-term by non-pregnant adults if they also eat healthy, exercise, and get counseling from a doctor.
Demand for these hunger-reducing GLP-1 drugs has exploded since 2021. The amount spent on GLP-1 agonists in the US hit nearly $72 billion last year, which is over 500% more than in 2018, when they were mainly for diabetes. A month's supply can cost over a grand, and the WHO thinks most people won't be able to get them by 2030. The WHO wants better access with things like different prices for different incomes. They also want to stop fake versions of the drugs.
Demand for these hunger-reducing GLP-1 drugs has exploded since 2021. The amount spent on GLP-1 agonists in the US hit nearly $72 billion last year, which is over 500% more than in 2018, when they were mainly for diabetes. A month's supply can cost over a grand, and the WHO thinks most people won't be able to get them by 2030. The WHO wants better access with things like different prices for different incomes. They also want to stop fake versions of the drugs.